β2 adrenergic receptor polymorphisms and COPD exacerbations: a complicated story

Labaki, Wassim W.; Han, MeiLan K.

doi:10.1136/thoraxjnl-2019-213697

Cited by 1 publication

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Beyond some genetic factors, a considerable part of exacerbation cannot be explained by infection ( 8 , 9 ); infection is still regarded as one of the main reasons for exacerbation in COPD ( 6 , 10 ). Therefore, ratio indexes in peripheral blood, such as platelet–lymphocyte ratio (PLR), platelet × neutrophil/lymphocyte [systemic immune-inflammation index (SII)], and monocyte × neutrophil/lymphocyte [systemic inflammation response index (SIRI)], which generally served as markers of inflammation level, are studied widely, as well as hemogram indexes like platelet counts/mean platelet volume (PLT/MPV) and platelet counts/red cell distribution width (PLT/RDW) ratios on behalf of platelet and red cell activation ( 11 , 12 ).…”

Section: Introductionmentioning

confidence: 99%

The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease

Liu

Feng

et al. 2020

Front. Med.

View full text Add to dashboard Cite

Background: Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary and systemic inflammatory processes, and exacerbation of COPD represents a critical moment in the progression of COPD. Several biomarkers of inflammation have been proposed to have a predictive function in acute exacerbation. However, their use is still limited in routine clinical practice. The purpose of our study is to explore the prognostic efficacy of novel inflammatory hemogram indexes in the exacerbation among stable COPD patients.Method: A total of 275 stable COPD patients from the Shanghai COPD Investigation Comorbidity Program were analyzed in our study. Blood examinations, especially ratio indexes like platelet–lymphocyte ratio (PLR), platelet × neutrophil/lymphocyte ratio [systemic immune-inflammation index (SII)], and monocyte × neutrophil/lymphocyte ratio [systemic inflammation response index (SIRI)], lung function test, CT scans, and questionnaires were performed at baseline and routine follow-ups. Clinical characteristics and information of exacerbations were collected every 6 months. The relationship between hemogram indexes and diverse degrees of exacerbation was assessed by logistic regression. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were used to evaluate the ability of hemogram indexes to predict exacerbation of COPD. Furthermore, the discrimination and accuracy of combined indexes were measured by ROC and calibration curve.Result: There was a significant positive correlation between PLR levels and total exacerbation of COPD patients in a stable stage in a year. Also, the predictive ability of PLR exceeded any other ratio indexes, with an AUC of 0.66. SII and SIRI ranked second only to PLR, with an AUC of 0.64. When combining PLR with other indexes (sex, COPD year, and St. George's Respiratory Questionnaire scores), they were considered as the most suitable panel of index to predict total exacerbation. Based on the result of the ROC curve and calibration curve, the combination shows optimal discrimination and accuracy to predict exacerbation events in COPD patients.Conclusion: The hemogram indexes PLR, SII, and SIRI were associated with COPD exacerbation. Moreover, the prediction capacity of exacerbation was significantly elevated after combining inflammatory hemogram index PLR with other indexes, which will make it a promisingly simple and effective marker to predict exacerbation in patients with stable COPD.

show abstract